Document is current
Any future updates will be listed below
-
Authors
Otiti-Sengeri, Juliet
Mugisha, Derrick
Ngoma, Deogratias Badeseke
Lusobya, Rebecca Claire
Atukunda, Immaculate
Colebunders, Robert
- License Information
-
More Information
Article History
Received: 12 November 2025
Accepted: 13 May 2026
First Online: 21 May 2026
Declarations
:
: Ethics approval for the compassionate use of topical cidofovir 0.5% eye drops for mpox keratitis was obtained from the Ethics committee of the Antwerp University Hospital and the University of Antwerp (Project ID 8153-Edge N/A-BUN N/A). The study adhered to the tenets of the Declaration of Helsinki.
: Written informed consent was obtained from the patient for publication of this case report and any accompanying images.
: During preparation of this manuscript, the authors used GPT-5 Thinking (OpenAI) to improve organization and enhance clarity and readability. After this assistance, the authors reviewed, revised, and approved the text and took full responsibility for its integrity and accuracy.
: The authors declare no competing interests.
